125 related articles for article (PubMed ID: 8466590)
1. Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder.
Baker GB; Bornstein RA; Douglass AB; Van Muyden JC; Ashton S; Bazylewich TL
Mol Chem Neuropathol; 1993; 18(1-2):173-8. PubMed ID: 8466590
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of metabolites of norepinephrine in Tourette's syndrome.
Baker GB; Bornstein RA; Douglass AB; Carroll A; King G
Mol Chem Neuropathol; 1990 Dec; 13(3):225-32. PubMed ID: 2099785
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.
Khan AU; Dekirmenjian H
Am J Psychiatry; 1981 Jan; 138(1):108-10. PubMed ID: 7446760
[No Abstract] [Full Text] [Related]
4. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
[TBL] [Abstract][Full Text] [Related]
5. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety.
Pliszka SR; Maas JW; Javors MA; Rogeness GA; Baker J
J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1165-73. PubMed ID: 7982867
[TBL] [Abstract][Full Text] [Related]
6. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
Zametkin AJ; Hamburger SD
Biol Psychiatry; 1988 Feb; 23(4):350-6. PubMed ID: 3342265
[TBL] [Abstract][Full Text] [Related]
7. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
Shekim WO; Javaid J; Davis JM; Bylund DB
Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
[TBL] [Abstract][Full Text] [Related]
8. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine.
Shekim WO; Dekirmenjian H; Chapel JL
Am J Psychiatry; 1979 May; 136(5):667-71. PubMed ID: 434244
[TBL] [Abstract][Full Text] [Related]
9. [Neurochemical and neurotransmitter studies in patients with learning disabilities].
Matsuishi T; Yamashita Y
No To Hattatsu; 1999 May; 31(3):245-8. PubMed ID: 10355264
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity.
Shekim WO; Sinclair E; Glaser R; Horwitz E; Javaid J; Bylund DB
J Child Neurol; 1987 Jan; 2(1):50-6. PubMed ID: 3624828
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys.
Shekim WO; Dekirmenjian H; Chapel JL; Javaid J; Davis JM
J Pediatr; 1979 Sep; 95(3):389-94. PubMed ID: 469661
[TBL] [Abstract][Full Text] [Related]
12. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
Shekim WO; Javaid J; Dekirmenjian H; Chapel JL; Davis JM
Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295
[TBL] [Abstract][Full Text] [Related]
13. Biological and psychological aspects of a case of Gilles de la Tourette's syndrome.
Yeragani VK; Blackman M; Baker GB
J Clin Psychiatry; 1983 Jan; 44(1):27-9. PubMed ID: 6571833
[TBL] [Abstract][Full Text] [Related]
14. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.
Roy A; Guthrie S; Karoum F; Pickar D; Linnoila M
Arch Gen Psychiatry; 1988 Feb; 45(2):158-61. PubMed ID: 3337613
[TBL] [Abstract][Full Text] [Related]
15. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome.
Shen YC; Wang YF
Biol Psychiatry; 1984 Jun; 19(6):861-70. PubMed ID: 6743722
[TBL] [Abstract][Full Text] [Related]
16. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
Shekim WO; Dekirmenjian H; Chapel JL
Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine metabolism during heroin use.
Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M
Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
[TBL] [Abstract][Full Text] [Related]
18. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
Curtin F; Walker JP; Schulz P
J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
[TBL] [Abstract][Full Text] [Related]
19. High correlation of norepinephrine and its major metabolite excretion rates.
Linnoila M; Karoum F; Potter WZ
Arch Gen Psychiatry; 1982 May; 39(5):521-3. PubMed ID: 7092485
[TBL] [Abstract][Full Text] [Related]
20. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
